Caxton Associates LP Myriad Genetics Inc Transaction History

Caxton Associates LP

  • $2.65 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$16.45 - $25.88 $482,297 - $758,775
29,319 New
29,319 $533,000
Q3 2020

Nov 16, 2020
SELL
$11.25 - $14.75 $122,996 - $161,261
-10,933 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$10.69 - $16.49 $116,873 - $180,285
10,933 New
10,933 $124,000

Others Institutions Holding MYGN

# of Institutions
248
Shares Held
91.1M
Call Options Held
100K
Put Options Held
34K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email